Desvenlafaxine

From Wikipedia, the free encyclopedia

Desvenlafaxine
Systematic (IUPAC) name
4-[2-dimethylamino-1-(1-hydroxycyclohexyl)
ethyl]phenol
Identifiers
CAS number 93413-62-8
ATC code  ?
PubChem 125017
Chemical data
Formula C16H25NO2 
Mol. mass 263.375 g/mol
Synonyms O-desmethylvenlafaxine
Norvenlafaxine
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Desvenlafaxine succinate, marketed under the name Pristiq, is an antidepressant of the serotonin-norepinephrine reuptake inhibitor class from Wyeth. It is a metabolite of venlafaxine (Effexor).

It has completed Phase III trials and is waiting for approval by the U.S. Food and Drug Administration. Wyeth announced on January 23 that they received an "approvable" letter from the FDA for venlafaxine. Final approval to sell the drug is contingent on a number of things, including:

  • a satisfactory FDA inspection of Wyeth's Guayama, Puerto Rico facility, where the drug is to be manufactured;
  • several post-marketing commitments;
  • clarity by Wyeth around the company's product education plan for physicians and patients;
  • approval of desvenlafaxine's proprietary name, Pristiq.[1]

Wyeth expects the drug to be approved for sales in early 2007.[2]

  1. ^ (January 23, 2007). Wyeth Receives Approvable Letter From FDA For Pristiq (Desvenlafaxine Succinate) For The Treatment Of Major Depressive Disorder. Press release. Retrieved on 2007-04-04.
  2. ^ Wyeth (August 29, 2006). Re-formatted Data Submission Results in Extension of FDA Review for Desvenlafaxine Succinate. Press release. Retrieved on 2007-04-04.


Advanced Search
Included Web Search Engines


Safe Search

close

Top Matching Results

Occasionally Search.com will highlight specialized results that are based on the context of your query. Examples of specialized results include specific links to news, images, or video.

Top Matching Results may highlight information from other Search.com pages, content from the CNET Network of sites, or third party content. The listings are based purely on relevance. Search.com does not receive payment for listings in this section but our partners that provide this data may get paid for listing these products.

Sponsored Links

This section contains paid listings which have been purchased by companies that want to have their sites appear for specific search terms and related content. These listings are administered, sorted and maintained by a third party and are not endorsed by Search.com.

Search Results

Search.com sends your search query to several search engines at one time and integrates the results into one list which has been sorted by relevance using Search.com's proprietary algorithm. You can customize the list of search engines included in your metasearch from the preferences.

The search engines that are used in your metasearch may allow companies to pay to have their Web sites included within the results. To view the Paid Inclusion policy for a specific search engine, please visit their Web site. Search.com does not accept payment or share revenue with any search engine partner for listings in this section.